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Abstract
Human DiGeorge Critical Region 8 (DGCR8) is an essential microRNA (miRNA) processing factor that is activated via direct
interaction with Fe(III) heme. In order for DGCR8 to bind heme, it must dimerize using a dimerization domain embedded
within its heme-binding domain (HBD). We previously reported a crystal structure of the dimerization domain from human
DGCR8, which demonstrated how dimerization results in the formation of a surface important for association with heme.
Here, in an attempt to crystallize the HBD, we search for DGCR8 homologues and show that DGCR8 from Patiria miniata (bat
star) also binds heme. The extinction coefficients (e) of DGCR8-heme complexes are determined; these values are useful for
biochemical analyses and allow us to estimate the heme occupancy of DGCR8 proteins. Additionally, we present the crystal
structure of the Xenopus laevis dimerization domain. The structure is very similar to that of human DGCR8. Our results
indicate that dimerization and heme binding are evolutionarily conserved properties of DGCR8 homologues not only in
vertebrates, but also in at least some invertebrates.
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Introduction
microRNAs (miRNAs) are a class of ,22 nucleotide (nt) non-
codingRNAsthatnegativelyregulategeneexpressionbydestabiliz-
ing target mRNAs or inhibiting their translation [1,2]. Mature
miRNAs originate from primary transcripts (pri-miRNAs) that may
betranscribedasintronsofmRNAsorasindependenttranscripts[3].
InthefirststepofmiRNAprocessing,apri-miRNAiscleavedinthe
nucleustoproduceanintermediatecalledtheprecursormiRNA(pre-
miRNA), by a protein complex called the Microprocessor, which is
minimallycomposedoftheribonucleaseIIIenzymeDrosha,andthe
RNA-bindingpartnerDGCR8[4,5,6,7,8].pre-miRNAsareexport-
ed to the cytoplasm where they undergo additional cleavages by
anotherribonucleaseIIIenzymeDicertoproducemiRNAduplexes.
miRNA duplexes are then incorporated into the miRNA-induced
silencing complex (miRISC) and unwound into the mature single-
stranded form. DGCR8, the focus of this study, is required for pri-
miRNA processing both in vitro and in vivo [6,8,9,10]. The DGCR8
gene is heterozygously deleted along with about 30 other genes in
DiGeorgesyndromepatients[11].Dgcr8
+/2mousemodelsindicat-
ed pri-miRNA processing defects in the brain and neurological
defects and symptoms similar to those observed in DiGeorge
syndrome [12,13,14].
In addition to the well accepted role of recognizing pri-miRNAs
[15,16,17,18], we found that a truncated form of human DGCR8
called NC1 (residues 276–751) binds Fe(III) heme when overex-
pressed in E. coli and is fully active in reconstituted pri-miRNA
processing assays [16,19]. ApoNC1 dimer is activated for pri-
miRNA processing in vitro by Fe(III) (ferric) heme, but not by Fe(II)
(ferrous) heme [20]. These observations demonstrated the
functional importance of heme binding to DGCR8, especially
the redox state of the heme iron, in miRNA processing. Human
DGCR8 is composed of an N-terminal region that is required for
nuclear localization, a central heme-binding domain (HBD,
residues 276–498), two double-stranded RNA-binding domains
(dsRBDs, residues 500–700) and a C-terminal tail (CTT, residues
701–751) (Figure 1A). Recombinant human HBD binds Fe(III)
heme and displays an electronic absorption spectrum similar to
that of Fe(III) heme-bound NC1 [21]. The HBD is a dimer and
each HBD dimer binds one heme molecule. The HBD
coordinates the heme Fe(III) using two thiol/thiolate groups from
the highly-conserved Cys352 residues contributed by both
subunits (Figure 1B) [19].
We previously identified a conserved N-terminal region of
human HBD as a dimerization (sub)domain (residues 276–353),
and determined a crystal structure of the human DGCR8
dimerization domain [21]. This structure revealed an expansive
dimerization interface mediated mainly by hydrophobic interac-
tions. The structure contains a WW motif, which is comprised of
three anti-parallel b-strands [21]. Most previously characterized
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actions by associating with proline-rich peptide segments [22,23].
The WW motif of DGCR8 is structurally similar to other known
WW motifs [21]. However, the WW motif in DGCR8 is unlikely
to bind proline-containing peptides because the surface typically
used for peptide binding is occluded in the structure. Instead, the
DGCR8 WW motif forms a structural platform for dimerization
and aids heme binding [21]. Dimerization occurs in part through
formation of a b-sheet between the WW motif and a fourth
strand in the C-terminal neighboring region (residues 332–352)
of the partner subunit. This ‘‘domain swapped’’ conformation
allows proper spatial positioning of residues required for heme
binding, thus resulting in a heme-binding surface [21]. The
structure of the human DGCR8 dimerization domain provides
structural evidence to explain why dimerization of DGCR8 is
required for heme binding.
Our previous studies have been mostly focusing on the human
DGCR8 protein. Here we explore heme binding properties of
DGCR8 homologues, partially in pursuit to crystallize the HBD.
We show that the bat star (P. miniata) DGCR8 binds Fe(III) heme.
We present the crystal structure of the frog (X. laevis) DGCR8
dimerization domain. These results suggest that dimerization and
heme binding are evolutionarily conserved features of the DGCR8
family of miRNA processing factors.
Results
Heme Binding is Conserved in a Starfish DGCR8
In our pursuit to crystallize the DGCR8 HBD, we searched for
homologues within other organisms. DGCR8, along with its
partner nuclease Drosha, was only found in animals. We noticed
that while the sequences of mammalian DGCR8 HBDs are highly
similar to each other (for example, the mouse sequence is 96%
identical to the human), those from frog (Xenopus laevis) and bat star
(Patiria miniata), an echinoderm invertebrate [24], have diverged
from human (Figure 1C). The bat star HBD sequence shares lower
identity (41%) to human than that of frog HBD (80%).
Interestingly, the residues known to be critical for heme binding
in human, Cys352 [16], Trp329 [21] (Figure 1C, red stars), are
conserved in all three species. These observations suggest that the
bat star and frog DGCR8 may use a similar mechanism to bind
heme as the human.
To experimentally test heme binding and to seek new
opportunities for crystallization, we cloned, expressed in E. coli,
and purified the bat star and frog HBD-His6 (all HBD
constructs this paper refers to contain a non-cleavable C-
terminal His6 tag; they are abbreviated as HBD). The frog
HBD has been shown to bind Fe(III) heme [19]. Here we
report that, the purified bat star HBD displays an electronic
absorption spectrum with peaks at 367, 450 and 556 nm,
similar to those of human HBD, indicating that it also binds
Fe(III) heme (Figure 2A). In size exclusion chromatography
(SEC) analyses, the bat star HBD (26 kDa per subunit) eluted at
13.8 mL, which is similar to that of the human HBD dimer
(54 kDa) but is 2.6 mL earlier than that of a monomeric human
DGCR8 protein (residues 499–751, called NC9, 29 kDa). This
observation indicates that the Fe(III) bat star HBD is a dimer
(Figure 2B). These results suggest that heme binding and
dimerization are conserved at least among DGCR8 homologues
from mammals, amphibians and starfish.
Determination of the Extinction Coefficients and Heme
Contents of Fe(III) Heme-DGCR8 Complexes
To increase the chance of obtaining crystals and to facilitate
biochemical analysis of heme-DGCR8 complexes, we need to
estimate the heme occupancy of purified complexes. Overexpres-
sion of heme proteins in bacteria induces heme deficiency and
often results in the presence of both holo- and apo-proteins. Even
though we add d-aminolevulinic acid (d-ALA), a heme biosynthesis
Figure 1. Domain structure of DGCR8 and sequence alignment of the heme-binding domains. (A) Domain structure of human DGCR8
and schematics of the NC1 and HBD constructs used in this study. (B) Schematic of how the DGCR8 HBD binds Fe(III) heme. (C) Sequence alignment
of bat star, frog and human HBDs. Identical residues are shaded in black. Residues that are identical only between two species are shaded in gray. Red
stars denote residues in human HBD known to be important for heme binding. Secondary structure assignments derived from the crystal structure of
frog dimerization domain are shown below the sequences, with b-strands as green arrows and loops as bars.
doi:10.1371/journal.pone.0039688.g001
Figure 2. The bat star DGCR8 HBD binds heme as a dimer. (A)
Electronic absorption spectrum of bat star HBD. Peak wavelengths and
the corresponding extinction coefficients are labeled. (B) Size exclusion
chromatogram of the bat star HBD, obtained from the last step of the
purification procedure. The elution volumes of the dimeric human HBD
(54 kDa) and the monomeric human NC9 (29 kDa) proteins are
indicated as triangles. Inset, a sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) image of the 13.8-mL peak fraction of
bat star HBD.
doi:10.1371/journal.pone.0039688.g002
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biosynthesis pathway, the A450 nm/A280 nm ratio (the RZ value) of
recombinant DGCR8 proteins as calculated from electronic
absorption spectra often varies from preparation to preparation.
Until the current study, it has not been clear to what extent these
proteins were occupied by heme.
To answer this question, we determined the extinction
coefficients of various DGCR8-heme complexes, which in turn
allowed us to estimate their heme occupancy using electronic
absorption spectroscopy. For each DGCR8-heme complex, we
recorded the electronic absorption spectrum, determined the
heme concentration using the pyridine hemochromogen method
[25], and measured the protein concentration using the
Bicinchoninic Acid (BCA) protein assay [26]. The pyridine
hemochrome, formed after extraction of heme from the
complexes and reduction of the heme iron, has a sharp and
intense absorption peak at 557 nm that obeys Beer’s law over a
wide concentration range, allowing the concentration of heme
in the complex to be determined accurately [25]. The heme
concentration of a bat star HBD preparation was determined to
be 7.3 mM, and the extinction coefficient of the Fe(III) heme in
this protein at 450 nm (e450,heme) was determined to be
70 mM
21 cm
21 (Figure 2A and Table 1). The BCA method
measures cuprous (Cu
1+) ion produced in the reaction of
proteins with alkaline Cu
2+ (called the biuret reaction) and has
relatively low protein-to-protein variation [26]. The concentra-
tion of the same bat star HBD dimer protein described above
was estimated to be 7 mM. Thus the molar ratio of protein to
heme, or heme occupancy, was close to 100%. With the
confidence in the homogeneity of this complex, we further
estimated the extinction coefficient of the dimeric Fe(III) heme-
bound HBD at 280 nm (e280,holo)t ob e9 1 m M
21cm
21
(Figure 2A). This value is higher than that of the dimeric
apoHBD (e280,apo =48mM
21cm
21) as calculated from the
amino acid sequence [27], consistent with the expectation that
the extinction coefficient of the HBD complex at 280 nm is
contributed by both the protein and heme moieties. We
encounter situations where apoHBD is present in the bat star
HBD samples and the A450/A280 ratio is lower than e450/
e280,holo (0.77). In these cases, the heme occupancy (Oheme) may
be calculated using the following equation:
Oheme~
e280,apo|
A450
A280
e450{ e280,holo{e280,apo

|
A450
A280
Using the pyridine hemochromogen method, we determined
the e450 values of the human HBD and NC1 proteins and the e451
of the frog HBD to be 74, 74 and 72 mM
21cm
21, respectively
(Table 1). The essentially identical e450/451 values suggest that the
chemical environments of the Fe(III) heme are very similar in the
HBDs from human, frog and bat star, and regardless whether the
dsRBDs and CTT are present. The e450 of the human NC1 is
higher than the value we previously reported (58 mM
21cm
21)
[16]. However, the latter was determined via organic solvent
extraction of heme, followed by quantification using reverse-phase
high pressure liquid chromatography (HPLC). This procedure
may have underestimated the extinction coefficient value if the
heme extraction was incomplete.
The BCA assays estimated that the heme occupancy of the
human HBD, NC1 and frog HBD preparations used in these
experiments were less than 100%, thus their e280,holo could not
yet be confidently determined. We note that the absence of
imidazole and thiol-containing reducing reagents in the storage
buffer of bat star HBD may have contributed to the higher
heme content. Further investigation will be needed to confirm
this possibility.
Structure Determination of the Frog DGCR8 Dimerization
Domain
In initial crystallization screens, the frog HBD protein
appeared as red phase separation. An additive screen was
performed under the condition producing this phase separation.
Single crystals were obtained from the addition of tribasic
sodium citrate. These crystals lacked any color, suggesting that
heme was not bound to the protein. Nevertheless, they
diffracted X-ray to 1.9 A ˚ resolution and a complete data set
was collected (Table 2). The structure was solved using
molecular replacement with the human dimerization domain
structure as the search model. In the 2Fo2Fc map, clear and
continuous electron density was observed from Pro300 to
Cys354; the electron densities of the main chain and side
chain of Leu355 were present but were disconnected when
contoured at 1s level (the N- and C-terminal ends of the
electron density are shown in Figures 3A, 3B). We did not
detect electron density for the first 22 N-terminal residues
(#278–299) and the 142 residues at the C-terminus (#356–
497). The latter region is comprised of the central loop and the
C-terminal region of the frog HBD. Crystallographic refinement
was performed using a model containing DGCR8 residues 300–
355 and water molecules, and resulted in final R and Rfree
factors of 0.2068 and 0.2280, respectively (Table 2).
To determine if the missing electron density was due to lack
of ordered structures in the crystal or degradation of the HBD
protein over the prolonged period of crystallization, we dissolved
crystals and analyzed the protein using matrix-assisted laser
desorption ionization time of flight (MALDI-TOF) mass
spectrometry. The resulting mass spectra did not reveal any
full-length frog HBD at the expected molecular mass of
26,469 Da, as we have successfully achieved for the same
protein using the same instrument and a similar procedure in a
previous study [19]. Instead, we observed two main ions with
m/z of 4,445 and 6,820, respectively (Figure 4). These ions
Table 1. Extinction coefficients for homologous HBDs.
e366/367 (mM
21 cm
21) e450/451 (mM
21 cm
21) e556 (mM
21 cm
21)
Human HBD 6061 (366 nm) 7461 (450 nm) 14.260.3
Frog HBD 6263 (366 nm) 7263 (451 nm) 14.060.6
Bat star HBD 5963 (367 nm) 7064 (450 nm) 12.960.6
Human NC1 6262 (366 nm) 7462 (450 nm) 14.160.4
doi:10.1371/journal.pone.0039688.t001
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4,444 Da and 6,819 Da. The molecular mass of the residues
observed in the continuous electron density of the crystal
structure is 6,371 Da, which is close to the mass of the ion
observed at m/z of 6,820. Inclusion of neighboring Arg299,
His356, and Tyr357 into the calculation produces a fragment
with a molecular mass of 6,828 Da, which is very close to the
mass observed via mass spectrometry. Thus, our crystals
contained the dimerization domain generated through degrada-
tion of the HBD. Some neighboring residues likely existed in
the polypeptide chain in the crystals, but adopted flexible
conformation. We have not been able to identify the protein
fragment corresponding to the 4,445 m/z peak, either in the
electron density or via additional biochemical analyses due to
the limited amount of material. It is possible that this peak
represents a degradation product from the dimerization domain
or from another region of the HBD. In the mass spectrum, the
intensity of the 4,445 m/z peak is higher than that of the
6,820 m/z peak (Figure 4). However, because ionization
efficiency often negatively correlates with molecular mass, the
4444-Da species is not necessarily more abundant than the
6819-Da species in the crystals.
Structural Conservation of Dimerization and Heme
Binding
The frog dimerization domain crystal contains a single
polypeptide chain in the asymmetric unit. The chain forms a
dimer via a crystallographic twofold symmetry (Figure 3C). The
subunits in each dimer are held together by an extensive interface
mainly mediated by hydrophobic interactions. The WW motif
folds into three b-strands (b1–b3). After strand b3, the polypeptide
chain extends through a hinge loop into a fourth b-strand (b4) that
interacts with the WW motif of the partner subunit, forming a
continuous b-sheet and resulting in an apparently domain-
swapped dimer. All DGCR8 residues known to be important for
heme binding, including Pro351 [19], Cys352 [16] and Trp329
[21], cluster on a common surface (shown in red in Figure 3C).
With a modest conformational change, this surface could form a
pocket to accommodates the Fe(III) heme and allow the two
Cys352 side chains to coordinate the heme iron from both sides of
the heme plane.
The dimerization domain structure of frog DGCR8 is very
similar to that of human DGCR8 with some differences at the N-
and C-termini. Superimposition of the Ca atoms of the two
structures (Figure 3D) results in a low overall root mean square
deviation of 0.38 A ˚. This is not surprising given that only three
residues out of a total of 55 amino acids are different between the
human and frog dimerization domain sequences (Figure 1C).
Pro300 and Pro301 at the N-terminus of the frog structure are
shifted by about 7 A ˚ and 3 A ˚, respectively (Figure 3D). The
human DGCR8 dimerization domain was crystallized in the
presence of the N-terminal 22 amino acids (residues 276–297)
[21]. Even though these residues are disordered, with no electron
density observed, they may have contributed to the structural
differences at the N-terminus. In the structural superimposition,
the side chain of frog Cys354 points toward a direction distinct
from that of human Cys352, as supported by a relatively weak but
substantial electron density (Figure 3B). This observation suggests
that the conformation of this axial ligand of Fe(III) heme is flexible,
due to absence of heme and/or close proximity to the C-terminus.
Overall, the high degree of sequence and structural conservation
suggests that frog DGCR8 uses the same mechanism of
dimerization to aid heme binding as identified in human DGCR8
[19,21].
Discussion
Here we explore the heme binding and dimerization properties
of DGCR8 homologues. We show that both frog and bat star
homologues bind Fe(III) heme in the same manner as human
DGCR8. The structure of the dimerization domain of frog
DGCR8 is nearly identical to that of human DGCR8.
Among the known domains of DGCR8, the WW motif-
containing dimerization domain is a defining feature of the
DGCR8 family proteins. The sequences of over 40 DGCR8
homologues are available in the UniProt Knowledgebase (Uni-
ProtKB) and National Center for Biotechnology Information
(NCBI) databases. All of them can be uniquely identified when
only the dimerization domain sequences are used in the search. In
contrast, the two dsRBDs arranged in tandem (dsRBD1 and
dsRBD2) are found in many RNA-binding proteins that function
either in other steps of miRNA biogenesis, such as the HIV trans-
activator RNA (TAR)-binding protein (TRBP) and the protein
kinase R (PKR)-activating protein (PACT) [28,29], or in pathways
Table 2. Crystallographic statistics of the structure of the frog
DGCR8 dimerization domain.
Data collection Native
Space group P43212
Cell dimensions
a, b, c (A ˚) 39.89, 39.89, 82.13
a, b, c (u) 90, 90, 90
Resolution (A ˚) 80–1.9 (1.97–1.9)
Observed reflections 64,720
Unique reflections 5,640
Wavelength (A ˚) 1.54
Rsym 0.1 (0.459)
I/s(I) 21.23 (3.38)
Completeness (%) 99.1 (99.6)
Redundancy 11.5 (6.6)
Refinement
Resolution (A ˚) 35.9–1.9
No. of reflections used 5,593
Rwork 0.2068
Rfree 0.2280
Average B factor (A ˚ 2)
protein/water 34.773/37.255
Root mean square deviation
bond length (A ˚)/angles (u) 0.007/1.081
Content of asymmetric unit
No. of protein molecules 1
No. of protein
Residues/atoms 56/454
No. of solvent atoms 33
Ramachandran statistics
Allowed/generous/disallowed (%) 100/0/0
Rsym=ghklgi |Ii(hkl)2,I(hkl). |/ghkl gIi(hkl). Rwork=g|Fo–Fc|/gFo.
Rfree=g|Fo2Fc|/gFo, calculated using a random set containing 10% reflections
that were not included in refinement.
doi:10.1371/journal.pone.0039688.t002
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Staufen) [30]. Our studies show that both sequence and structure
of the dimerization domain are highly conserved ([21] and herein).
The dimerization domain is an integral part of the heme-
binding domain in human DGCR8; it aligns residues important
for heme-binding in proper spatial positions (Figure 3C) [21]. We
are interested to investigate if heme binding is also a conserved
feature of DGCR8. Beyond the dimerization domain, the central
loop region (containing at least residues 377–410 in human
DGCR8) is dispensable for heme binding and is poorly conserved
(Figure 1C). We recently showed that a function of the central loop
is to present a site for cleavage of DGCR8 by caspases, which
results in inhibition of its pri-miRNA processing activity [31]. The
C-terminal region of the HBD (residues 411–498 in humans) is
required for heme binding [21] and is modestly conserved. It is not
clear yet how the C-terminal region contributes to association with
Figure 3. Crystal structure of the frog DGCR8 dimerization domain. (A–B) 2Fo-Fc electron density maps, contoured at 1s level, of the N- and
C-terminal regions of the frog dimerization domain, respectively. (C) Wall-eyed stereo diagram of the crystal structure of frog dimerization domain.
The dimer subunits are colored green and blue. Secondary structures from the green subunit are denoted with a prime. The crystallographic two-fold
axis relating the two subunits is indicated by the arrow. Residues known to be important for heme binding are highlighted in red. (D)
Superimposition of human (orange) and frog (blue) dimerization domain Ca traces shown in stereo.
doi:10.1371/journal.pone.0039688.g003
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uses two cysteine side chains as coaxial ligands for binding Fe(III)
heme [19]. The axial ligand Cys352 and its immediate neighbor-
ing residue Pro351 are completely conserved. Trp329, which is
also important for human DGCR8 to bind Fe(III) heme, is
conserved in mammals, birds, lizards, amphibians, fish and
starfish, but not in insects and worms. The relationship between
conservation of Trp329 and heme binding will be addressed in a
separate study. Overall, our study supports the Fe(III) heme-
mediated activation of pri-miRNA processing as a common
mechanism not only among vertebrates, but also in at least some
invertebrates.
Materials and Methods
Plasmid Construction
The coding sequence of bat star DGCR8 HBD (residues 180–
392), was amplified from a partial cDNA (NCBI Accession
number GQ397480) using PCR and was cloned into pET-24a
+
(Novagen), between the NdeI and XhoI sites. The coding
sequence of the plasmid was verified via sequencing.
Protein Expression and Purification
The human, frog and bat star HBD-His6 proteins were
expressed in E. coli strain BL21-CodonPlus (DE3)-RIPL (Strata-
gene, a part of Agilent Technologies) and purified using Ni-affinity
chromatography followed by size exclusion chromatography,
similar to the procedure previously used for human HBD-His6
[21]. A heme biosynthesis intermediate d-aminolevulinic acid (MP
Biomedicals) was added to a final concentration of 1 mM at the
time of induction. In Ni
2+ affinity chromatography, both the lysis
and wash buffers contained 500 mM NaCl, 10 mM imidazole,
and 20 mM Tris pH 8.0; the elution buffer contained the same
components except 200 mM imidazole. The SEC buffer con-
tained 400 mM NaCl, 20 mM Tris pH 8.0, and 1 mM dithio-
threitol (DTT). In the purification of bat star HBD-His6, the
protein was immediately buffer-exchanged into 400 mM NaCl
and 20 mM Tris pH 8.0 after affinity chromatography, prior to
storage at 4uC overnight and the SEC purification step in the
following day. The buffer exchange used here and below was
achieved using Amicon Ultracel centrifugal concentrators with
Molecular Weight Cutoff’s of 10 or 30 kDa (EMD Millipore,
Billerica, MA).
The human NC1 protein was expressed and purified as
previously described [16].
Pyridine Hemochromogen Assay and Determination of
Extinction Coefficients and Heme Occupancy
Reducing reagents were removed from the purified NC1 and
HBD proteins via buffer exchange to avoid interference with the
BCA assay. Same protein stock solutions were then used in both
pyridine hemochromogen and BCA assays. Pyridine hemochro-
mogen assays were performed as described [25]. Briefly, 500 mLo f
a stock solution containing 0.2 M NaOH and 40% pyridine and
3 mL of 0.1 M potassium ferricyanide were mixed with 500 mLo f
protein solution in a cuvette. The oxidized absorption spectrum
was recorded between 500 and 600 nm using a Cary 300
spectrophotometer (Varian, Palo Alto, CA), with the spectral
bandwidth set to 0.5 nm and in single beam mode. A few crystals
of sodium dithionite were added to the solution, mixed well, and
the reduced spectrum was recorded. Heme concentration was
determined using Beer’s law (A=eC). The A557 was the absorbance
at 557 nm from the reduced spectrum, and the e557 is
34.53 mM
21cm
21. After the heme concentration (C) was deter-
mined, the extinction coefficients (e) of the DGCR8-Fe(III) heme
complex were calculated, again using Beer’s law, from the
electronic absorption spectra of the native protein at the
wavelengths where only heme absorbed.
Protein concentrations were determined using the Micro BCA
Protein Assay kit (Thermo Fisher Scientific, Rockford, IL)
following to the manufacturer’s protocol. Heme occupancy is
defined as the molar ratio of heme and dimeric proteins in the
complexes.
Crystallization
In an effort to crystallize the frog HBD in a thiol-oxidized state,
this protein was treated with 10 mM oxidized glutathione (GSSG)
at pH 8.0 for 20 min. GSSG was removed via buffer exchange
into a low-salt buffer containing 200 mM NaCl, 20 mM Tris
pH 8.0, and 5 mM DTT. Crystallization trials were set up using a
Mosquito robot (TTP LabTech, Cambridge, MA) and hanging
drop vapor diffusion method. Frog HBD at ,10 mg/mL
was mixed in a 1:1 (v/v) ratio with a well solution containing
20% (w/v) polyethylene glycol (PEG)-1000, 0.1 M imidazole
pH 8.0, and 0.2 M calcium acetate, with 1 M tribasic sodium
citrate added to the drop to 10% of final drop volume. Crystals
were grown at 18uC in 4 months. Single crystals were soaked in a
cryo-protection solution, containing all the components of the well
solution and 20% glycerol, for 5 min at 18uC, mounted with
CrystalCap HT Cryoloops (Hampton Research), and flash-frozen
in liquid nitrogen prior to data collection.
Data Collection, Structure Determination, Refinement
and Analysis
Diffraction images were collected using a Rigaku R-AXIS-IV++
imaging plate detector and Cu Ka X-ray radiation from a Rigaku
FRE+ rotating anode generator with confocal optics. Data were
processed using HKL2000 [32]. Initial phases were calculated via
molecular replacement using the program PHASER [33,34] with
the human dimerization domain structure (PDB code 3LE4) as the
search model. An initial model was built using ARP/wARP [35],
followed by manual model building using COOT [36] and
refinement using REFMAC [37] and PHENIX [38]. Structural
superposition was performed using the program MAPS [39].
Coordinates and structure factor amplitudes have been deposited
in the RCSB Protein Data Bank with accession code 4E5R.
Figure 4. MALDI-TOF mass spectrometry analysis of crystals
obtained from frog DGCR8 HBD. Ions with a ‘‘+1’’ charge state are
labeled with their corresponding m/z values. The ion with m/z of 6820.0
roughly corresponds to the dimerization domain observed in the crystal
structure.
doi:10.1371/journal.pone.0039688.g004
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Crystals were dissolved in a buffer containing 400 mM NaCl,
20 mM Tris pH 8.0, and 1 mM DTT. The solution was
desalted using Omix C18 tips (Agilent Technologies, Santa
Clara, CA) according to the manufacturer’s protocol. Sinapinic
acid dissolved in 70% acetonitrile and 0.1% trifluoroacetic acid
was used as the matrix and was mixed with the desalted protein
solution in a 1:1 (v/v) ratio. Data were obtained on a Voyager
DE STR MALDI-TOF mass spectrometer (Applied Biosystems,
Foster City, CA), set in the linear mode and with m/z range of
2,000–30,000. Data were plotted using Prism (version 4.0,
GraphPad, La Jolla, CA).
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